Introduction {#s1}
============

Tuberculosis (TB) is a chronic infectious disease that occurs worldwide, leading to 1.6 million deaths annually worldwide [@pone.0088448-Zembrzuski1]. However, from the estimated 2 billion individuals that have been initially infected with *Mycobacterium tuberculosis (M. tuberculosis)*, only 5% to 10% develop symptomatic TB [@pone.0088448-Kleinnijenhuis1]. The exact reasons as to why only some of the individuals exposed to *M. tuberculosis* develop uncontrolled disease and others have an effective immune response to limit the spread of the pathogen remains unknown. The genetic influence on TB infection was established by several studies of monozygotic and dizygotic twins, linkage and candidate gene analysis, indicating that genetics may play a role in the susceptibility to TB infection [@pone.0088448-Hill1]--[@pone.0088448-Vannberg1].

A major determinant for the clinical expression of the different forms of TB, and their final outcome, is the interaction between the pathogen and the host immune system. Cytokines play an important role in anti-TB immune response, and cytokines interleukin -10 (IL-10) have been implicated in the pathogenesis of TB [@pone.0088448-Knight1]. IL-10 is an important immunoregulatory cytokine mainly produced by macrophages, monocytes, T cells, B cells, dendritic cells, mast cells and eosinophils [@pone.0088448-Ouyang1]. Turner J, *et al.* demonstrated that increased susceptibility to reactivation tuberculosis in the mouse model is strongly influenced by the expression of IL-10 during the chronic or latent phase of the infection [@pone.0088448-Turner1]. IL-10 potentially helps *M. tuberculosis* persistence in humans by blocking phagosome maturation in macrophages [@pone.0088448-OLeary1]. The ability of IL-10 to down-regulate immune responses and the fact that IL-10 can be detected in tuberculosis patients have led researchers to investigate whether IL-10 plays a role in susceptibility to tuberculosis [@pone.0088448-Barnes1], [@pone.0088448-Verbon1].

Certain single nucleotide polymorphisms within the promoter region of the IL-10 gene have been associated with altered levels of circulating IL-10, such as −1082G/A, −819T/C, and −592A/C [@pone.0088448-Crawley1], [@pone.0088448-Maurer1]. These polymorphisms have been investigated as potential susceptibility factors for TB. Given the functional significance of this genetic variant, a number of case-control studies have been done in different populations to investigate its susceptibility towards TB, but the findings remain conflicting rather than conclusive. Therefore, we conducted a systematic review and meta-analysis to get a more precise estimate of the association between IL-10 polymorphisms and TB risk.

Materials and Methods {#s2}
=====================

Literature Search Strategy {#s2a}
--------------------------

A literature search was conducted among six English databases (PubMed, Embase, Web of Science, Science Direct, SpringerLink and EBSCO) and two Chinese databases (Wanfang and Chinese National Knowledge Infrastructure databases) to identify studies involving association between IL-10 −1082G/A, −819T/C, and −592A/C polymorphisms and TB susceptibility before May. 2013. Key words used in the research included "interleukin", "interleukin-10", "cytokine", "tuberculosis", "*Mycobacterium tuberculosis*", "single nucleotide polymorphism", "variant", "genotype", "mutation". To minimize potential publication bias, no restrictions were placed on language, sample size, and time period.

Inclusion and Exclusion Criteria

All included studies have to fulfill the following characteristics and inclusion criteria: (a) case-control studies focused on associations between IL-10 -1082G/A, -819T/C, and −592A/C polymorphisms and the risk of TB; (b) the diagnosis of TB should meet the internationally accepted criteria; (c) genotype distribution in both cases and controls were available for estimating an odds ratio (OR) with 95% confidence interval (CI). The exclusion criteria of the meta-analysis were: (a) animal studies; (b) meta-analyses, letters, reviews, meeting abstracts, or editorial comments; (c) studies with duplicate data, incomplete data, and unavailable data. When an individual author published several articles obtained from the same patient population, only the newest or most complete article was included in the analysis.

Data Extraction {#s2b}
---------------

Data were independently abstracted by two reviewers (Liang and Li) using a standard protocol and data-collection according to the inclusion criteria. The following data were collected from each study: first author's name, year of publication, country, ethnicity, source of controls, sample size, genotyping method, and number of cases and controls for IL-10 −1082G/A, −819T/C, and −592A/C polymorphisms. An attempt was made to contact authors if data presentation was incomplete or if it was necessary to resolve an apparent conflict or inconsistency in the article. Any disagreements were resolved by consensus.

Statistical Analysis {#s2c}
--------------------

Review manager 5.0 program provided by the Cochrane Library and Stata (Version12.0, Stata Corporation) were used to perform all the statistical analysis. The combined odds ratio (OR) with its 95% confident interval (CI) was used to assess the strength of the association between the IL-10 polymorphisms and TB risk. The significance of the combined OR was determined by the Z-test, in which *P*\<0.05 was considered significant. The pooled ORs were calculated for allele model (mutation \[M\] allele versus wild \[W\] allele), dominant model (WM+MM versus WW), recessive model (MM versus WM+WW), homozygote comparison (MM versus WW), and heterozygote comparison (WM versus WW), respectively. Two models of pooling data for dichotomous outcomes were conducted: the random-effects model and the fixed-effects model. Heterogeneity assumption was assessed by the Chisquare based Q test and was regarded to be statistically significant if *P*\<0.10. When the *P*≥0.10, the pooled statistical analysis was calculated by the fixed-effects model, otherwise, a random-effect model was used. To evaluate the ethnicity-specific effects, subgroup analyses were performed by ethnic group. The potential publication bias was assessed by Begg's funnel plot and Egger's test [@pone.0088448-Begg1], [@pone.0088448-Egger1].

Results {#s3}
=======

Characteristics of Studies {#s3a}
--------------------------

The flow chart that displays the study selection process was shown in [Figure 1](#pone-0088448-g001){ref-type="fig"}. A total of 31 case-control studies, including 6,559 cases and 7,768 controls, were finally identified according to inclusion and exclusion criteria. There are 29 case-control studies concerning -1082G/A polymorphism [@pone.0088448-Wu1]--[@pone.0088448-Ma1], 14 case-control studies concerning -819T/C polymorphism [@pone.0088448-Wu1], [@pone.0088448-Selvaraj1], [@pone.0088448-Bellamy1]--[@pone.0088448-Henao1], [@pone.0088448-Ates1], [@pone.0088448-Liang1], [@pone.0088448-Thye1], [@pone.0088448-Trajkov1]--[@pone.0088448-Amirzargar1], [@pone.0088448-Liu1], [@pone.0088448-Mhmoud1], and 16 case-control studies concerning -592A/C polymorphism [@pone.0088448-Wu1], [@pone.0088448-Bellamy1]--[@pone.0088448-Ates1], [@pone.0088448-Shin1], [@pone.0088448-Liang1], [@pone.0088448-Thye1], [@pone.0088448-Trajkov1]--[@pone.0088448-Taype1], [@pone.0088448-Mhmoud1], [@pone.0088448-Meilangqucuo1]. Among the 31 eligible studies, 17 of them were of Asians [@pone.0088448-Wu1], [@pone.0088448-Selvaraj1], [@pone.0088448-RamaseriSunder1], [@pone.0088448-Delgado1], [@pone.0088448-Shin1], [@pone.0088448-Oh1]--[@pone.0088448-Ansari1], [@pone.0088448-Ansari2], [@pone.0088448-Meenakshi1], [@pone.0088448-Amirzargar1], [@pone.0088448-PrabhuAnand1]--[@pone.0088448-Ma1], [@pone.0088448-Meilangqucuo1], 6 studies were of Europeans [@pone.0088448-Scola1], [@pone.0088448-Oral1], [@pone.0088448-Ates1], [@pone.0088448-Ulger1], [@pone.0088448-LopezMaderuelo1], [@pone.0088448-Trajkov1], 5 studies were of Africans [@pone.0088448-Bellamy1], [@pone.0088448-BenSelma1], [@pone.0088448-Mosaad1], [@pone.0088448-Thye1], [@pone.0088448-Fitness1], and 3 studies were of Americans [@pone.0088448-Henao1], [@pone.0088448-GarciaElorriaga1], [@pone.0088448-Taype1]. Controls were selected from healthy population in all studies and most studies used frequency-matched controls to the cases by age, sex, or ethnicity. The genotype distributions among the controls of all studies were in agreement with HWE except for ten studies for the -1082G/A, two studies for the -819T/C, and three studies for the -592A/C. The detailed characteristics of the eligible studies included in this meta-analysis were shown in [Table 1](#pone-0088448-t001){ref-type="table"}.

![Flow diagram of the literature search and trial selection process.](pone.0088448.g001){#pone-0088448-g001}
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###### Baseline characteristics of the 31 eligible studies for the analysis of IL-10 polymorphism.

![](pone.0088448.t001){#pone-0088448-t001-1}

  Studies               Year    Country    Ethnicity   Source of controls   Sample size          SNP studied           Genotyping method            HWE
  -------------------- ------ ----------- ----------- -------------------- ------------- ---------------------------- ------------------- -----------------------
  Wu F                  2008     China       Asian             HB             61/122      -1082G/A, -819T/C, -592A/C       PCR-RFLP         0.379, 0.125, 0.125
  Scola A               2003     Italy     European            PB             45/114               -1082G/A                ARMS-PCR               \<0.001
  Selvaraj P            2008     India       Asian             PB             155/183         -1082G/A, -819T/C            PCR-RFLP            0.204, 0.174
  Sharada RS            2012     India       Asian             HB             104/102              -1082G/A                ARMS-PCR                0.057
  Bellamy R             1998    Gambia      African            HB             401/408     -1082G/A, -819T/C, -592A/C        PCR-SSP         0.824, 0.779, 0.779
  Oral HB               2006    Turkey     European            HB              81/50      -1082G/A, -819T/C, -592A/C        PCR-SSP         0.060, 0.320, 0.320
  Ben-Selma W           2011   Tunisian     African            HB             131/95      -1082G/A, -819T/C, -592A/C       PCR-RFLP         0.020, 0.957, 0.957
  Heno MI               2006   Colombia    American            HB             190/135     -1082G/A, -819T/C, -592A/C        PCR-SSP         0.674, 0.410, 0.518
  Garcia-Elorriaga G    2006    Mexico     American            HB              77/60          -1082G/A, -592A/C             Taqman            0.728, \<0.001
  Ates O                2008    Turkey       Asian             HB             128/80      -1082G/A, -819T/C, -592A/C       ARMS-PCR         0.978, 0.819, 0.819
  Delgado JC            2002   Cambodian     Asian             HB             356/106             -1082G/A,                PCR-RFLP               \<0.001
  Ulger M               2013    Turkey     European            HB             84/110               -1082G/A                PCR-RFLP               \<0.001
  Shin HD               2005     Korea       Asian             HB             449/851         -1082G/A, -592A/C              MAPA              0.168, 0.631,
  Mosaad YM             2010     Egypt      African            HB             110/118              -1082G/A                ARMS-PCR               \<0.001
  Oh JH                 2007     Korea       Asian             HB             145/117              -1082G/A                ARMS-PCR                0.612
  Liang L               2011     China       Asian             HB             235/78      -1082G/A, -819T/C, -592A/C    SNaPshot assay      0.589, 0.253, 0.253
  Ansari A              2009   Pakistan      Asian             PB             178/376              -1082G/A                ARMS-PCR               \<0.001
  Thye T                2009     Ghana      African            PB            2010/2346    -1082G/A, -819T/C, -592A/C         FRET           0.542, 0.380, 0.551
  Ansari A              2011   Pakistan      Asian             PB             102/166              -1082G/A                ARMS-PCR               \<0.001
  Lopez-Maderueyo D     2003     Spain     European            HB             113/100              -1082G/A                ARMS-PCR                0.949
  Meenakshi P           2013     India       Asian             HB             100/100              -1082G/A                PCR-RFLP                0.058
  Mhmoud N              2013     Sudan       Asian             HB             191/206          -819T/C, -592A/C            PCR-RFLP          \<0.001, \<0.001
  Mei                   2012     China       Asian             HB             169/156              -592A/C                 PCR-RFLP                0.622
  Ma Z                  2007     China       Asian             HB              40/40               -1082G/A                 PCR-SSP                0.292
  Yang H                2010     China       Asian             HB             198/200              -1082G/A                 PCR-SSP                0.253
  Liu XX                2009     China       Asian             HB             141/135         -1082G/A, -819T/C            PCR-RFLP          \<0.001, \<0.001
  Trajkov D             2009   Macedonia   European            PB             75/299      -1082G/A, -819T/C, -592A/C        PCR-SSP        \<0.001, 0.879, 0.403
  Fitness J             2004    Malawi      African            HB             210/705     -1082G/A, -819T/C, -592A/C       ARMS-PCR         0.524, 0.062, 0.035
  Amirzargar AA         2006     Iran        Asian             HB             41/123      -1082G/A, -819T/C, -592A/C        PCR-SSP        \<0.001, 0.671, 0.671
  Taype CA              2010     Peru      American            HB             626/513         -1082G/A, -592A/C           Taqman PCR           0.142, 0.055
  Prabhu Anand S        2007     India       Asian             HB             132/143              -1082G/A                PCR-RFLP                0.123

PB, population-based controls, HB, hospital-based controls. HWE, Hardy--Weinberg equilibrium. PCR, polymerase chain reaction; SSP, sequence-specific primers; ARMS, amplification refractory mutation system; RFLP, restriction fragment length polymorphism; FRET, fluorescence resonance energy transfer. MAPA, multiplex automated primer extension analysis.

Quantitative Data Synthesis {#s3b}
---------------------------

The evaluation of association between IL-10 polymorphisms and TB risk was presented in [Table 2](#pone-0088448-t002){ref-type="table"}.

10.1371/journal.pone.0088448.t002

###### Determination of the genetic effects of ***IL-10*** polymorphisms on TB and subgroup analysis.

![](pone.0088448.t002){#pone-0088448-t002-2}

                        Allele model           Dominant model      Recessive model     Homozygous model   Heterozygous model                                                                 
  -------------- --------------------------- ------------------ --------------------- ------------------ --------------------- -------- --------------------- -------- --------------------- --------
  **-1082G/A**    **A allele vs. G allele**   **AA+GA vs. GG**    **AA vs. GG+GA**      **AA vs. GG**        **GA vs. GG**                                                                   
  overall            0.97 \[0.79--1.20\]            0.81         0.95 \[0.68--1.34\]         0.79         0.92 \[0.75--1.14\]    0.46    0.90 \[0.61--1.33\]    0.59    0.99 \[0.72--1.36\]    0.96
  Asian              1.15 \[0.89--1.47\]            0.27         1.48 \[0.69--3.17\]         0.32         1.24 \[0.91--1.69\]    0.17    1.65 \[0.74--3.72\]    0.22    1.39 \[0.67--2.90\]    0.38
  European           0.75 \[0.56--1.01\]            0.05         0.57 \[0.37--0.89\]         0.01         0.67 \[0.36--1.26\]    0.21    0.53 \[0.26--1.08\]    0.08    0.60 \[0.39--0.93\]    0.02
  African            1.13 \[0.62--2.07\]            0.69         1.03 \[0.85--1.25\]         0.78         0.76 \[0.53--1.09\]    0.13    0.84 \[0.56--1.24\]    0.37    1.09 \[0.90--1.32\]    0.40
  American           0.58 \[0.32--1.06\]            0.07         0.39 \[0.27--0.57\]        \<0.01        0.53 \[0.20--1.41\]    0.20    0.31 \[0.13--0.77\]    0.01    0.46 \[0.32--0.68\]   \<0.01
  **-819T/C**     **C allele vs. T allele**   **CC+TC vs. TT**    **CC vs. TC+TT**      **CC vs. TT**        **TC vs. TT**                                                                   
  overall            0.98 \[0.92--1.05\]            0.59         1.03 \[0.85--1.25\]         0.77         0.87 \[0.73--1.05\]    0.15    0.98 \[0.85--1.12\]    0.73    1.09 \[0.85--1.41\]    0.49
  Asian              0.83 \[0.72--0.96\]            0.01         0.94 \[0.57--1.54\]         0.80         0.60 \[0.40--0.90\]    0.01    0.63 \[0.45--0.88\]   0.006    1.10 \[0.57--2.10\]    0.78
  European           1.09 \[0.84--1.41\]            0.51         1.27 \[0.70--2.31\]         0.43         1.08 \[0.75--1.56\]    0.67    1.33 \[0.71--2.49\]    0.38    1.19 \[0.63--2.24\]    0.59
  African            1.02 \[0.94--1.10\]            0.62         1.08 \[0.94--1.25\]         0.27         0.99 \[0.88--1.11\]    0.88    1.06 \[0.90--1.25\]    0.46    1.09 \[0.93--1.27\]    0.29
  American           1.00 \[0.72--1.38\]            1.00         0.89 \[0.48--1.64\]         0.71         1.06 \[0.68--1.66\]    0.79    0.94 \[0.49--1.81\]    0.85    0.85 \[0.44--1.63\]    0.62
  **-592A/C**     **C allele vs. A allele**   **CC+AC vs. AA**    **CC vs. AC+AA**      **CC vs. AA**        **AC vs. AA**                                                                   
  overall            0.99 \[0.83--1.18\]            0.90         0.89 \[0.74--1.08\]         0.25         0.92 \[0.78--1.09\]    0.32    0.87 \[0.68--1.11\]    0.27    0.90 \[0.76--1.07\]    0.24
  Asian              0.69 \[0.57--0.85\]           \<0.01        0.65 \[0.49--0.85\]        0.002         0.62 \[0.49--0.79\]   \<0.01   0.49 \[0.34--0.71\]   \<0.01   0.70 \[0.55--0.89\]   \<0.01
  European           1.19 \[0.92--1.54\]            0.18         1.47 \[0.81--2.66\]         0.20         1.18 \[0.85--1.65\]    0.32    1.57 \[0.85--2.90\]    0.15    1.34 \[0.72--2.52\]    0.36
  African            1.01 \[0.92--1.10\]            0.90         1.10 \[0.94--1.30\]         0.24         0.95 \[0.83--1.08\]    0.45    1.06 \[0.88--1.27\]    0.54    1.14 \[0.96--1.35\]    0.14
  American           1.56 \[1.08--2.27\]            0.02         1.04 \[0.79--1.36\]         0.79         1.24 \[0.92--1.69\]    0.16    1.26 \[0.94--1.69\]    0.13    0.86 \[0.64--1.15\]    0.30

Of the 31 studies investigating the association between IL-10 -1082G/A polymorphism and TB susceptibility, 29 provided enough data to calculate ORs, including 6,199 cases and 7,406 controls. The results of pooling all studies showed that the IL10 -1082 G/A polymorphism was not associated with TB susceptibility in general population under all genetic models (A allele vs. G allele: OR =  0.97, 95% CI = 0.79--1.20, *P* = 0.81; AA+GA vs. GG: OR =  0.95, 95% CI  =  0.68--1.34, *P* = 0.79; AA vs. GA+ GG: OR =  0.92, 95% CI = 0.75--1.14, *P* = 0.46; AA vs. GG: OR =  0.90, 95% CI = 0.61--1.33, *P* = 0.59; GA vs. GG: OR =  0.99, 95% CI = 0.72--1.36, *P* = 0.96) ([Figure 2](#pone-0088448-g002){ref-type="fig"}). In the stratified analysis by ethnicity, we found that TB risk was significant decreased in European group under dominant model ([Figure 2](#pone-0088448-g002){ref-type="fig"}) (AA+GA vs. GG: OR =  0.57, 95% CI  =  0.37--0.89, *P* = 0.01) and heterozygous model (GA vs. GG: OR =  0.60, 95% CI = 0.39--0.93, *P* = 0.02). However, no significant association between this polymorphism and TB risk was observed in other comparison models in European group. Moreover, significant increased TB risk was observed in dominant model ([Figure 2](#pone-0088448-g002){ref-type="fig"}) (AA+GA vs. GG: OR =  0.39, 95% CI  =  0.27--0.57, *P*\<0.01), homozygous model (AA vs. GG: OR =  0.31, 95% CI = 0.13--0.77, *P* = 0.01), and heterozygous model (GA vs. GG: OR =  0.46, 95% CI = 0.32--0.68, *P*\<0.01) in American group.

![Meta-analysis with a random-effect model for the ORs of tuberculosis risk associated with IL-10 -1082G/A polymorphism in dominant genetic model comparison.](pone.0088448.g002){#pone-0088448-g002}

A total of 3,584 cases and 4,584 controls from 14 case-control studies were included for data synthesis. The results showed that there was no statistically significant association between IL-10 -819C/T polymorphism and TB risk in general population (C allele vs. T allele: OR =  0.98, 95% CI = 0.92--1.05, *P* = 0.59; CC+TC vs. TT: OR =  1.03, 95% CI  =  0.85--1.25, *P* = 0.77; CC vs. TC+TT: OR =  0.87, 95% CI = 0.73--1.05, *P* = 0.15; CC vs. TT: OR =  0.98, 95% CI = 0.85--1.12, *P* = 0.73; TC vs. TT: OR =  1.09, 95% CI = 0.85--1.41, *P* = 0.49) ([Figure 3](#pone-0088448-g003){ref-type="fig"}). In the stratified analyses for the -819C/T polymorphism, there was a significantly decreased risk was observed among Asians in allele model (C allele vs. T allele: OR =  0.83, 95% CI = 0.72--0.96, *P* = 0.01), homozygous model (CC vs. TT: OR =  0.60, 95% CI = 0.40--0.90, *P* = 0.01), and heterozygous model (TC vs. TT: OR =  0.63, 95% CI = 0.45--0.88, *P* = 0.006).

![Meta-analysis with a random-effect model for the ORs of tuberculosis risk associated with IL-10 -819T/C polymorphism in dominant genetic model comparison.](pone.0088448.g003){#pone-0088448-g003}

A total of 4,063 cases and 5,326 controls from 16 case-control studies were included for data synthesis. In the current meta-analysis, we did not find a significant relationship between IL-10 -592A/C polymorphism and TB risk (C allele vs. A allele: OR =  0.99, 95% CI = 0.83--1.18, *P* = 0.90; CC+AC vs. AA: OR = 0.89, 95% CI  =  0.74--1.08, *P* = 0.25; CC vs. AC+AA: OR =  0.92, 95% CI = 0.78--1.09, *P* = 0.32; CC vs. AA: OR =  0.87, 95% CI = 0.68--1.11, *P* = 0.27; AC vs. AA: OR = 0.90, 95% CI = 0.76--1.07, *P* = 0.24) ([Figure 4](#pone-0088448-g004){ref-type="fig"}). In the subgroup analysis by ethnicity, the results indicated that there was significant association between IL-10 -592A/C polymorphism and TB risk in Asians under all gene models (C allele vs. A allele: OR =  0.69, 95% CI = 0.57--0.85, *P*\<0.01; CC+AC vs. AA: OR = 0.65, 95% CI  =  0.49--0.85, *P* = 0.002; CC vs. AC+AA: OR =  0.62, 95% CI = 0.49--0.79, *P*\<0.01; CC vs. AA: OR =  0.49, 95% CI = 0.34--0.71, *P*\<0.01; AC vs. AA: OR = 0.70, 95% CI = 0.55--0.89, *P*\<0.01), but not in Europeans, Africans, and Americans, suggesting genetic diversity among ethnicities.

![Meta-analysis with a random-effect model for the ORs of tuberculosis risk associated with IL-10 -592A/C polymorphism in dominant genetic model comparison.](pone.0088448.g004){#pone-0088448-g004}

Publication Bias {#s3c}
----------------

Begg's funnel plot and Egger's test were performed to assess the publication bias of included studies. The shapes of the funnel plots did not reveal any evidence of obvious asymmetry under the dominant model (-1082G/A, *P* = 0.953; -819T/C, *P* = 0.661; -592A/C, *P* = 0.685) ([Figure. 5](#pone-0088448-g005){ref-type="fig"}). Egger's test also did not show any significantly statistical evidence of publication bias under the dominant model (-1082G/A, *P* = 0.992; -819T/C, *P* = 0.981; -592A/C, *P* = 0.712), which indicated low risk of publication bias in this meta-analysis.

![Funnel plot for publication bias of the meta-analysis of tuberculosis risk and IL-10 polymorphisms in dominant genetic model comparison.\
(a) IL-10 -1082G/A polymorphism, (b) IL-10 -819T/C polymorphism, (c) IL-10 -592A/C polymorphism.](pone.0088448.g005){#pone-0088448-g005}

Discussion {#s4}
==========

To date, convincing evidence indicate that the outcome of TB is modulated by the environment as well as bacterial and host genetic components. Many investigations have confirmed that cytokines appear to play the critical roles in the development of TB. Polymorphisms in several cytokine genes have been described and demonstrated to influence gene transcription, leading to interindividual variations in cytokine [@pone.0088448-Pan1]. IL-10 is a powerful T helper 2 regulatory cytokine and plays an essential role during the latent TB stage, where increased production of this cytokine promotes reactivation of disease in mice [@pone.0088448-Turner1] and suppression of cell-mediated immunity against the intracellular infection [@pone.0088448-Moller1]. IL-10 gene is located on the long arm of chromosome 1, where several polymorphisms have been identified within the promoter region, such as −1082G/A, −819T/C, and −592A/C. Genetic studies showed that IL-10 polymorphisms in the promoter region were associated with TB risk, and a number of studies have been performed to investigate that association. However, inconclusive results were obtained. To provide further investigation into these controversial points, a meta-analysis is needed to achieve a more reliable and comprehensive conclusion.

Based on a meta-analysis from 18 studies that contained 4740 cases and 5919 controls, Zhang J, *et al*. found that -819C/T and -592A/C polymorphisms do not affect susceptibility to TB, while the -1082G/A polymorphism was significantly associated with decreased risk of TB only in Europeans [@pone.0088448-Zhang1]. Our meta-analysis, which involved 31 studies including 6559 cases and 7768 controls, also found that the presence of the -1082G/A, -819T/C, and -592A/C genotypes was not associated with the risk of TB in the general population. In our analysis, there was evidence of heterogeneity between studies. It may be due to some factors, including the ethnicity, the selection of methods, definition of cases, and sample sizes.

As recent reports showed that genotype frequencies at IL-10 vary greatly in different populations, particularly in individuals of different ethnicities [@pone.0088448-Meenagh1], a subgroup analysis was conducted in our study. Our subgroup analyses showed that the IL-10 -1082G/A genotype significantly decreased TB risk in Europeans and Americans, but not in Asians or Africans. The individuals who carry variant A allele (AA+GA) had a nearly 43% and 63% decreased risk of TB in Europeans and Americans, respectively, suggesting a possible role of ethnic differences in genetic backgrounds and environmental exposures. In stratified analyses for IL-10 -819 T/C, we observed a significant association between IL-10 -819 T/C polymorphism and TB risk in Asians under allele model, recessive model, and homozygous model. We also observed an association between IL-10 -592A/C polymorphism and TB risk in Asians under all gene models. In the case of European population, there were only 4 studies containing 284 cases and 429 controls for IL-10 -819T/C and IL-10 -592A/C polymorphisms analysis. As for American population, there were only one study containing 190 cases and 235 controls for IL-10 -819T/C polymorphism analysis. Therefore, our results should be interpreted with caution, and more case-control studies based on larger sample size of the different ethnicity population should be carried out in the future.

Some limitations of this meta-analysis should be considered when explaining our results. First, given that only published studies were included in the meta-analysis, publication bias may be present, although our results of publication bias showed no significance. Second, some studies were not in agreement with the HWE, making the sample a poor representation. Third, significant between-study heterogeneity was observed in some comparisons, and as such, results may be distorted. Different ethnic populations and different sources of controls may contribute to the heterogeneity. Forth, the interaction of different susceptibility genes and environment factors leaded to the disease, but our study could not assess gene-gene and gene-environment interactions due to the limited information of included studies. Last, but not the least, meta-analysis remains a retrospective research that is subject to the methodological deficiencies of the included studies. In view of these limitations, further studies should focus on the associations of gene polymorphisms and clinical or laboratory characteristic in a large cohort of TB patients.

Conclusion {#s5}
==========

In conclusion, despite the several considerations mentioned above, this meta-analysis indicated that three polymorphisms (-1082G/A, -819T/C, and -592A/C) in the IL-10 gene were not associated with the risk of TB in general population. In the subgroup analysis, IL-10 -1082G/A polymorphism was associated with TB risk in Europeans and Americans, and IL-10 -819T/C and -592A/C polymorphisms were significantly associated with TB risk in Asians. In the future, additional large studies are warranted to validate our findings. Future studies should include multi-ethnic groups and use standardized unbiased genotyping methods, and well-matched controls.
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